NEED ORDER STATUS? Click Here
Order

Ophthalmic Portfolios

ImprimisRx® formulates compounded medications typically prescribed by physicians in the ophthalmic industry, and is one of the largest compounding pharmacies servicing both optometry and ophthalmology. ImprimisRx® is committed to delivering high-quality formulations that are required to meet applicable U.S. Pharmacopeia (USP) or current guidelines. Click here to learn more about our quality standards.

Dropless Cataract Surgery

Dropless® Injectable Formulation*

  • Tri-Moxi+™  (triamcinolone and moxifloxacin hydrochloride)
  • Dex-Moxi® (dexamethasone and moxifloxacin hydrochloride)*
  • Dex-Moxi-Ketor® (dexamethasone, moxifloxacin hydrochloride and ketorolac)*

Less Drops Combination Drop Therapy

Combination Topical Drop Formulations*

Non-invasive sublingual conscious sedation provides consistent predictable dosing.

Oral Sedation Formulation*

  • MKO Melt® (midazolam, ketamine and ondansetron)*

 Topical Formulations*

  • Klarity® (Glycerin and dextran based vehicle ophthalmic solution PF)*
  • Klarity-A®Drops (azithromycin 1% ophthalmic solution PF)*
  • Klarity-C Drops® (cyclosporine 0.1% ophthalmic emulsion PF)*
  • Klarity-L®(loteprednol etabonate 0.5% ophthalmic suspension PF)*
  • Klarity-CL (cyclosporine 0.1%/loteprednol etabonate 0.2% ophthalmic suspension PF)*

Patients may need to take more than one eye drop product pursuant to multiple dosing regimens, as directed by his or her prescriber, in order for the active ingredients to remain effective throughout the day.

Preservative-Free Topical Formulations*

Topical Formulations Typically Prescribed by Physicians in the Ophthalmic Market

Injectable Formulations Typically Prescribed by Physicians in the Ophthalmic Market

1-11 of 29 Results for Ophthalmic Portfolios

Formulation Classification Strength
Brim-Dor® PF (Brimonidine/Dorzolamide)* – 10mL Topical Medication 0.15/2%
Dex-Moxi-Ketor®* – 1mL – Single Use Vial Injectable 1mg/0.5mg/0.4mg/mL
Klarity-A® Drops (Azithromycin ophthalmic solution PF) * Topical Medication 1%
Klarity-C Drops® (Cyclosporine 0.1% ophthalmic emulsion PF)* Topical Medication 0.1%
Klarity-CL Drops (Cyclosporine 0.1% / Loteprednol Etabonate 0.2% ophthalmic suspension PF)* Topical Medication 0.1% / 0.2%
Klarity-L® Drops (Loteprednol Etabonate 0.5% ophthalmic suspension PF)* Topical Medication 0.5%
Klarity Drops® (Glycerin 1% ophthalmic solution PF)* – 10mL Topical Medication 1%
Moxi-Brom (Moxifloxacin/Bromfenac)* – 5mL Topical Medication 0.5/0.075%
Moxifloxacin 0.8mg/0.8mL* – Single-Use Vial Injectable 0.8mg/0.8mL (1mg/mL)
Moxifloxacin 4mg/0.8mL* – Single-Use Vial Injectable 4mg/0.8mL (5mg/mL)
Mydriatic 2 (Tropicamide/Phenylephrine)* – Multi-Dose 10 mL Topical Medication 1/2.5%
Previous Next
formualtion search

Formulations

Search over 3,500 compounded formulations.

*For professional use only. ImprimisRx® specializes in customizing medications to meet unique patient and practitioner needs.  ImprimisRx® dispenses these formulations only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.

Reference. 1.Data on file.